- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Silver47 Exploration
Purpose Bitcoin ETF
Jindalee Lithium
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
DIAGNOS announced the addition of a new medical partner, Garuda Health Services, to cover the country of Cambodia.
DIAGNOS (TSXV:ADK; OTCQB:DGNOF) announced the addition of a new medical partner, Garuda Health Services, to cover the country of Cambodia.
As quoted in the press release:
Garuda Health Services (GHS) first customer will be Royal Phnom Penh Hospital. A new screening service will be offered to their clientele at their annual physical exam. The service is scheduled to be launched in late fall of this year and should cover 22,400 patients under their care. DIAGNOS’ CARA solution will provide automatic detection and classification of Diabetic Retinopathy disease. Detection of anomalies for AMD (Age Macular Degeneration) is also planned to be available. In early 2018, CARA Cardio is scheduled to be added as a new screening service for cardio vascular diseases.
“In adding eye screening with retina anomalies detection, we are increasing the number of health points to better determine the global health of our patients. This will significantly help us to prevent disease evolution and take early action. As DIAGNOS is developing new algorithms to detect more illness, we will be ready to use them.
Click here to read the full press release.
Source: www.marketwired.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â